Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study

Further Exploration of the Relationship Between Insulin Glargine and Incident Cancer: A retrospective cohort study of older Medicare patients

(2011) N. E. Morden et al.   DIABETES CARE

Long-term effects of insulin glargine on the risk of breast cancer

(2011) S. Suissa et al.   DIABETOLOGIA

Cancer Risk Associated with Insulin Glargine among Adult Type 2 Diabetes Patients – A Nationwide Cohort Study

(2011) Chia-Hsuin Chang et al.   PLoS One

Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma

(2010) Manal M. Hassan et al.   CANCER

Diabetes, Insulin Use, and Cancer Risk: Are Observational Studies Part of the Solution-or Part of the Problem?

(2010) J. A. Johnson et al.   DIABETES

Associations of Hyperglycemia and Insulin Usage With the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry

(2010) X. Yang et al.   DIABETES

Doses of Insulin and Its Analogues and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients

(2010) E. Mannucci et al.   DIABETES CARE

Diabetes and Cancer: A consensus report

(2010) E. Giovannucci et al.   DIABETES CARE

Diabetes therapy and cancer risk: causal effects and other plausible explanations

(2010) S. Hernández-Díaz et al.   DIABETOLOGIA

Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure

(2010) S. L. Bowker et al.   DIABETOLOGIA

Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies

(2010) B. H. Ch. Stricker et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Diabetes Mellitus Type 2 – An Independent Risk Factor for Cancer?

(2010) V. Grote et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Does Insulin Therapy Promote, Reduce, or Have a Neutral Effect on Cancers?

(2010) Hertzel C. Gerstein   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

(2010) The Emerging Risk Factors Collaboration   LANCET

Insulin Glargine and Cancer Risk: An Opinion Statement of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy

(2010) Krystal L Edwards et al.   PHARMACOTHERAPY

Treatment with insulin glargine (Lantus®) increases the proliferative potency of the serum of patients with type-1 diabetes: a pilot study on MCF-7 breast cancer cells

(2010) Doris Mayer et al.   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY

Combined randomised controlled trial experience of malignancies in studies using insulin glargine

(2009) P. D. Home et al.   DIABETOLOGIA

Diabetes treatment with insulin glargine and risk of malignancy: methodological pitfalls and ethical issues

(2009) D. Simon   DIABETOLOGIA

Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study

(2009) J. Rosenstock et al.   DIABETOLOGIA

Does diabetes therapy influence the risk of cancer?

(2009) U. Smith et al.   DIABETOLOGIA

Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden

(2009) J. M. Jonasson et al.   DIABETOLOGIA

No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis

(2009) A. Dejgaard et al.   DIABETOLOGIA

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

(2009) H. M. Colhoun et al.   DIABETOLOGIA

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

(2009) C. J. Currie et al.   DIABETOLOGIA

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

(2009) L. G. Hemkens et al.   DIABETOLOGIA

Diabetes and cancer

(2009) Paolo Vigneri et al.   ENDOCRINE-RELATED CANCER

Insulin glargine and malignancy: an unwarranted alarm

(2009) Stuart J Pocock et al.   LANCET

Proliferative effects of insulin analogues on mammary epithelial cells

(2008) Doris Mayer et al.   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY